Navigation Links
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
Date:8/1/2011

f Arena's most advanced drug candidate and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review and approval is uncertain; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the CRL for the lorcaserin NDA or submission of a Marketing Authorization Application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; the FDA may request other information prior to or after Arena submits such response or approval of the lorcaserin NDA; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looki
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
2. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
3. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
7. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
9. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
10. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ) has ... Biologic Drug Discovery Outsourcing Market" report to their ... market will likely grow in a CAGR of 23% ... by 2020. It has been widely recognized ... new but important type of medication. They provide not ...
(Date:7/7/2015)... June 30, 2015 ... addition of the "Deciphering Global Major Pharmaceutical ... to their offering. It has been ... been involved in a series of challenges in ... resulted in significant overcapacities in small molecule product ...
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3
... PASADENA, Calif. March 2, 2011 Men who take non-steroidal ... months are 2.4 times more likely to have erectile dysfunction ... according to a Kaiser Permanente study published online in ... research showed a trend toward this same finding, this observational ...
... The U.S. Food and Drug Administration today took ... unapproved prescription oral cough, cold, and allergy products. The ... States. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... have not been evaluated by the FDA for safety, ...
Cached Medicine Technology:Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 3FDA Prompts Removal of Unapproved Drugs From Market 2FDA Prompts Removal of Unapproved Drugs From Market 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised ... surpassing their original 2015 fundraising goal by nearly $100,000, to help support ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today ... website that helps active people find the most fun activities to do with friends. ... for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading ... aims to give back to the community through company-wide volunteering efforts. , On an ... dedicate the day to assisting those in need throughout Baltimore and Washington D.C. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time to get outside ... is sharing some safety tips. , Jean Tapley, senior wellness coordinator at Amica, suggests ... , Start slowly. Going from no activity to several hours of ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... Program will celebrate inspiring scientists and their commitment to ... advance global ... to,scientific advancement, Pfizer Inc will launch Think Science Now, a science,awareness ... the mysteries of biology, chemistry and human disease.,A major part of ...
... 24 Americans are experiencing,rising prices on many ... drugs represent one of the fastest-growing medical,expenses. From ... from,$40.3 billion to $200.7 billion, according to a ... To help, Giant is introducing a new way ...
... Devices known as brain-machine interfaces could someday be used ... limbs with just their thoughts. Now, University of Florida ... a way for computerized devices not only to translate ... the brain as it learns. , Instead of simply ...
... Kristen Michelle,Masterson is this year,s Miss Fairfield ... has supervised Kristen,s volunteer,patient care activities over these ... a nurse. "Her compassion for those that are ... one of our pediatric patients or,to our young ...
... June 24 , WHO: Martin Payne, Executive ... Leigh Hocker Radtke, Director, Software Product ... 2:00 PM - ... Inventory Management DESCRIPTION: Medical sales processes are becoming increasingly ...
... Systems Further Royal, Brompton and Harefield NHS Trust,s Leadership ... ... LOUIS, June 24 Stereotaxis, Inc. (Nasdaq:,STXS) announced that British Prime ... of the art electrophysiology lab at,Royal Brompton Hospital in London. The ...
Cached Medicine News:Health News:Pfizer Launches 'Think Science Now' 2Health News:Pfizer Launches 'Think Science Now' 3Health News:Pfizer Launches 'Think Science Now' 4Health News:New Giant Pharmacy Program Offers Relief for Your Family and Your Wallet 2Health News:Researchers develop neural implant that learns with the brain 2Health News:Researchers develop neural implant that learns with the brain 3Health News:Connecticut Hospice Has Miss Fairfield on Its Side 2Health News:Connecticut Hospice Has Miss Fairfield on Its Side 3Health News:SkyeTek to Host Webinar Discussing RFID-Based Solution for Medical Sales Processes Automation 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 3
... EIA Kit is a direct antigen detection system, ... It uses polyclonal and monoclonal antibodies to detect ... combines the specificity and reproducibility of monoclonal antibodies ... Qualitative results are availalbe within 90 minutes. ...
... Every Bard BrachyStar® Needle is designed ... an efficient and clinically effective brachytherapy procedure. ... featuring ultra-sharp tips and polished surfaces for ... of needle configurations and sizes assures an ...
... Bard Brachytherapy loaders allow for efficient, ... SourceLink™ Connectors to your customized plans ... of Bard loaders is the flexibility ... flexibility in the QuickLoad™ Loader allows ...
... BrachySource iodine-125 implant is a combination of ... visibility that makes BrachySource I-125 implant an ... can be confident that every BrachySource I-125 ... management services which is required by clinicians ...
Medicine Products: